Elaine Kingwell

2211 Wesbrook Mall, V6T 2B5
Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 18, 2026

Exploring the relationship between polycystic ovarian syndrome, testosterone, and multiple sclerosis in women: A nationwide cohort study and genome-wide cross-trait analysis.

Exploring the relationship between polycystic ovarian syndrome, testosterone, and multiple sclerosis in women: A nationwide cohort study and genome-wide cross-trait analysis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: November 06, 2024

Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study.

Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study.

Journal: Annals of neurology

Published: August 14, 2023

Association of multiple-sclerosis-related mortality with COVID-19 and other common infections: a multiple causes of death analysis.

Association of multiple-sclerosis-related mortality with COVID-19 and other common infections: a multiple causes of death analysis.

Journal: European journal of neurology

Published: November 09, 2022

Sex and age differences in the Multiple Sclerosis prodrome.

Sex and age differences in the Multiple Sclerosis prodrome.

Journal: Frontiers in neurology

Published: August 12, 2022

Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival.

Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: January 24, 2022

Disease-modifying drugs for multiple sclerosis and subsequent health service use.

Disease-modifying drugs for multiple sclerosis and subsequent health service use.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 24, 2021

Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population.

Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population.

Journal: Frontiers in immunology

Published: October 13, 2021

Care consumption of people with multiple sclerosis: A multichannel sequence analysis in a population-based setting in British Columbia, Canada.

Care consumption of people with multiple sclerosis: A multichannel sequence analysis in a population-based setting in British Columbia, Canada.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 28, 2021

Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study.

Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study.

Journal: BMJ open

Published: February 07, 2021

A multiple sclerosis disease progression measure based on cumulative disability.

A multiple sclerosis disease progression measure based on cumulative disability.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: January 25, 2021

Short-term laboratory and related safety outcomes for the multiple sclerosis oral disease-modifying therapies: an observational study.

Short-term laboratory and related safety outcomes for the multiple sclerosis oral disease-modifying therapies: an observational study.

Journal: Expert opinion on drug safety

Published: December 21, 2020

Showing 1-12 of 71

Last Updated: 09/26/2026